Erik Strömqvist

Swiss Nuclides AG provides diagnostics and radiopharmaceutical therapy treatment services for cancer patients. The company is based in Aarau, Switzerland. The Swiss company was founded by Leila Jaafar-Thiel and Gustav von Schulthess, and Leila Jaafar-Thiel has been the CEO since incorporation.

The Swedish company was founded by Sture Lindegren, Milton Lönnroth, and Emma Aneheim, with Milton Lönnroth serving as CEO since incorporation.

The Swedish company was founded by Sture Lindegren, Milton Lönnroth, and Emma Aneheim, with Milton Lönnroth serving as CEO since incorporation.

MedTrace Pharma A/S provides medical devices for hospital departments. The firm developed several novel safety features, which combined will revolutionize blood flow imaging in PET. The company’s solution consists of a remote operated unit producing the radioactive water and two disposable kits, including a daily kit for production, and a patient kit for infusion. It aims to make radioactive water (O-15 H2O) practically available for clinical use allowing doctors to use the gold standard in the clinic. The company is headquartered in Vedbaek, Denmark.

Swiss Nuclides AG provides diagnostics and radiopharmaceutical therapy treatment services for cancer patients. The company is based in Aarau, Switzerland. The Swiss company was founded by Leila Jaafar-Thiel and Gustav von Schulthess, and Leila Jaafar-Thiel has been the CEO since incorporation.

Swiss Nuclides AG provides diagnostics and radiopharmaceutical therapy treatment services for cancer patients. The company is based in Aarau, Switzerland. The Swiss company was founded by Leila Jaafar-Thiel and Gustav von Schulthess, and Leila Jaafar-Thiel has been the CEO since incorporation.

MedTrace Pharma A/S provides medical devices for hospital departments. The firm developed several novel safety features, which combined will revolutionize blood flow imaging in PET. The company’s solution consists of a remote operated unit producing the radioactive water and two disposable kits, including a daily kit for production, and a patient kit for infusion. It aims to make radioactive water (O-15 H2O) practically available for clinical use allowing doctors to use the gold standard in the clinic. The company is headquartered in Vedbaek, Denmark.

The Swedish company was founded by Sture Lindegren, Milton Lönnroth, and Emma Aneheim, with Milton Lönnroth serving as CEO since incorporation.

MedTrace Pharma A/S provides medical devices for hospital departments. The firm developed several novel safety features, which combined will revolutionize blood flow imaging in PET. The company’s solution consists of a remote operated unit producing the radioactive water and two disposable kits, including a daily kit for production, and a patient kit for infusion. It aims to make radioactive water (O-15 H2O) practically available for clinical use allowing doctors to use the gold standard in the clinic. The company is headquartered in Vedbaek, Denmark.

The Swedish company was founded by Sture Lindegren, Milton Lönnroth, and Emma Aneheim, with Milton Lönnroth serving as CEO since incorporation.

MedTrace Pharma A/S provides medical devices for hospital departments. The firm developed several novel safety features, which combined will revolutionize blood flow imaging in PET. The company’s solution consists of a remote operated unit producing the radioactive water and two disposable kits, including a daily kit for production, and a patient kit for infusion. It aims to make radioactive water (O-15 H2O) practically available for clinical use allowing doctors to use the gold standard in the clinic. The company is headquartered in Vedbaek, Denmark.